Public Profile

Vernalis Limited

Vernalis Limited, a prominent player in the biotechnology sector, is headquartered in Great Britain and operates extensively across Europe and North America. Founded in 2000, the company has established itself as a leader in drug discovery and development, focusing on innovative solutions for unmet medical needs. Vernalis is renowned for its unique approach to small molecule drug design, leveraging its proprietary technologies to enhance the efficacy and safety of therapeutic candidates. The company’s core services include medicinal chemistry, structural biology, and preclinical development, which have positioned it as a trusted partner for pharmaceutical companies. With a strong track record of collaborations and successful product advancements, Vernalis Limited continues to make significant strides in the industry, contributing to the advancement of healthcare solutions globally.

DitchCarbon Score

How does Vernalis Limited's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.

23

Industry Average

Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.

33

Industry Benchmark

Vernalis Limited's score of 23 is lower than 84% of the industry. This can give you a sense of how well the company is doing compared to its peers.

16%

Let us know if this data was useful to you

Vernalis Limited's reported carbon emissions

Vernalis Limited, headquartered in Great Britain, currently does not have publicly available carbon emissions data for recent years. As a result, specific figures regarding their Scope 1, 2, or 3 emissions are not provided. Additionally, there are no documented reduction targets or climate pledges outlined in their initiatives. In the absence of specific emissions data, it is important to note that many companies in the pharmaceutical and biotechnology sectors are increasingly focusing on sustainability and reducing their carbon footprints. Vernalis Limited may be engaging in similar efforts, although details on their specific commitments or initiatives are not available at this time.

Industry emissions intensity

Very low
Low
Medium
High
Very high
Some industries are more carbon intensive than others. Vernalis Limited's primary industry is Pharmaceutical Preparation Manufacturing, which is very low in terms of carbon intensity compared to other industries.

Location emissions intensity

Very low
Low
Medium
High
Very high
The carbon intensity of the energy grid powering a company's primary operations has a strong influence on its overall carbon footprint. This request for Vernalis Limited is in GB, which has a low grid carbon intensity relative to other regions.

Reduction initiatives & disclosure networks

Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.

Vernalis Limited is not participating in any of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.

Science Based Targets Initiative
Carbon Disclosure Project
The Climate Pledge
UN Global Compact
RE 100
Climate Action 100
Race To Net Zero
Reduction Actions

Similar Organizations

MorphoSys

DE
Other business services (74)
Updated 1 day ago

Indivior

US
Pharmaceutical Preparation Manufacturing
Updated 2 days ago

Basilea Pharmaceutica

CH
Health and social work services (85)
Updated 2 days ago

Ablynx NV

BE
Health and social work services (85)
Updated 3 days ago
DitchCarbon Score

Evotec

DE
Research and development services (73)
Updated 1 day ago

Almirall

ES
Pharmaceutical Preparation Manufacturing
Updated 2 days ago

Where does DitchCarbon data come from?

Discover our data-driven methodology for measuring corporate climate action and benchmarking against industry peers